PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan 20139, Italy. Electronic address: m.kamal@aucegypt.edu.\', \'Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan 20139, Italy; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Ain Shams University, Cairo, Egypt.\', \'Biology Department, School of Science and Engineering, American University in Cairo, New Cairo 11835, Egypt. Electronic address: ahmed.abdellatif@aucegypt.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0306-9877(20)33256-410.1016/j.mehy.2020.110365
?:doi
?:hasPublicationType
?:journal
  • Medical hypotheses
is ?:pmid of
?:pmid
?:pmid
  • 33221134
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.443
?:rankingScore_hIndex
  • 75
?:title
  • Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33221134>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33221134>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all